Tag : Parkinson039s

Neurology

Lanthionine ketimine ester improves outcome in an MPTP-induced mouse model of Parkinson's disease via suppressions of CRMP2 phosphorylation and microglial activation

Newsemia
Parkinson’s disease (PD) is characterized by progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc). Levodopa (L-Dopa), the current main treatment for...
Latest News

What contributes to quality of life in Parkinson's disease: a re-evaluation

Newsemia
Schrag, A; Quinn, N; (2020) What contributes to quality of life in Parkinson’s disease: a re-evaluation. Journal of Neurology, Neurosurgery & Psychiatry 10.1136/jnnp-2019-322379 . (In...
Latest News

Impulse control and related behaviors in Parkinson's disease with dementia

Newsemia
Martinez-Martin, P; Wan, YM; Ray Chaudhuri, K; Schrag, AE; Weintraub, D; (2020) Impulse control and related behaviors in Parkinson’s disease with dementia. European Journal of...
AI/ML

Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort study.

Newsemia
Related Articles Personalized prediction of depression in patients with newly diagnosed Parkinson’s disease: A prospective cohort study. J Affect Disord. 2020 Feb 28;268:118-126 Authors: Gu...
AI/ML

Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson's disease.

Newsemia
Related Articles Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease. Artif Intell Med. 2020 Mar;103:101807 Authors: Tsiouris KM, Konitsiotis S,...
Neurology

Relative Contribution of Magnetic Resonance Imaging, Microelectrode Recordings, and Awake Test Stimulation in Final Lead Placement during Deep Brain Stimulation Surgery of the Subthalamic Nucleus in Parkinson's Disease.

Newsemia
Related Articles Relative Contribution of Magnetic Resonance Imaging, Microelectrode Recordings, and Awake Test Stimulation in Final Lead Placement during Deep Brain Stimulation Surgery of the...
Neurology

Concordance of mini-mental state examination, Montreal cognitive assessment and Parkinson Neuropsychometric Dementia Assessment in the classification of cognitive performance in Parkinson's disease

Newsemia
Cognitive impairment (CI) is frequently observed in Parkinson’s disease (PD) and negatively influences the patient’s and carer’s quality of life. As a first step, assessment...
Neurology

Scientists identify gene as potential therapeutic target for dementia in people with Parkinson's

Newsemia
Dementia is one of the most debilitating consequences of Parkinson’s disease, a progressive neurological condition characterized by tremors, stiffness, slow movement and impaired balance. Source...
Pediatrics

Parkinson's Before Birth; Diabetes Drugs and Alzheimer's; 102 Autism Genes

Newsemia
<![CDATA[]]>(MedPage Today) — Young-onset Parkinson’s disease may start before birth, a stem cell study suggested. (Nature Medicine) Three putatively neuroprotective drugs — amiloride, fluoxetine (Prozac),...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy